GL1X · GenesisL1 explorer

Research workbench

Crystal structure of cov-2 NSP3 macrodomain complex with PARG345

Analyse Crystal structure of cov-2 NSP3 macrodomain complex with PARG345 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7LG7
Type
protein
Length
167 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-structural protein 3
UniProt
P0DTD1
Ligands
XYJ, SO4
Pockets
1 · best druggability 0.54

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANon-structural protein 3protein16737% helix, 20% strandP0DTD1

Ligands and binding sites

  • XYJ · 3-[(1,3-dimethyl-2,6-dioxo-2,3,6,9-tetrahydro-1H-purin-8-yl)sulfanyl]-N-{[2-(morpholin-4-yl) ethyl]sulfonyl}propanamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12060.540.7835XYJ

Compared structures

  • 7LG7 · Crystal structure of CoV-2 Nsp3 Macrodomain complex with PARG345 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.